About Index Trending news
Analyze
Pricing
Aerie Pharmaceuticals

Aerie Pharmaceuticals

Work at Aerie Pharmaceuticals? Add yourself to this profile

Aerie Pharmaceuticals

Aerie Pharmaceuticals is focused on developing products for the pharmaceuticaltreatment of glaucoma.

Elsewhere

Contributors to this profile

Alexa global traffic share

16 Mar 2017
$40,000,000
Undisclosed
Novartis Venture Fund, OrbiMed, Kearny Venture Partners, +3

Aerio Pharmaceuticals takes in about $40 mln

PE Hub
09 Sep 2014
$125,000,000
Post-IPO equity
07 Mar 2011
$41,364,965
Venture capital (Series B)